Bon usage des hémostatiques en chirurgie cardiaque

Bleeding during cardiac surgery can be a serious or deadly complication: extracorporeal circulation, using a high level of anticoagulant therapy, and the patient's weakness are the main factors of intra- and postoperative bleeding. Managing this risk means prevention before and during the intervention. When intraoperative bleeding is uncontrollable or inaccessible for classic suture or swab, the use of local hemostatic agents provides an effective treatment. Medical correction of hemostasis anomalies is also a way of managing postoperative bleeding. The eventual additional cost of these new products has yet to be objectively counterbalanced by their efficacy in terms of reducing the length of the hospital stay. These local hemostatic agents must be available to the surgeon in cardiac surgery.